Poltreg S.A. (WSE:PTG)

Market Cap	112.41M -26.3%
Revenue (ttm)	n/a
Net Income	-27.31M
EPS	-5.86
Shares Out	5.92M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,457
Open	19.00
Previous Close	19.00
Day's Range	18.05 - 19.40
52-Week Range	16.00 - 36.00
Beta	0.91
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 9, 2026

About Poltreg

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdańsk, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 37
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: PTG

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 14, 2026

Data Sources Report a data error